Roderick Wong - 16 Jun 2021 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Role
Director, 10%+ Owner
Signature
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
Issuer symbol
RNA
Transactions as of
16 Jun 2021
Transactions value $
$0
Form type
4
Filing time
17 Jun 2021, 12:53:13
Previous filing
16 Jun 2021
Next filing
31 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNA Stock Option (Right to Buy) Award $0 +15K $0.00 15K 16 Jun 2021 Common Stock 15K $26.09 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on the board of directors of the Issuer through such vesting date.